CytoDyn Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CYDY Over the counter 8731 https://www.cytodyn.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CytoDyn Inc

CytoDyn Announces Company Updates and Investment Community Update Webcast - Jul 11th, 2023 8:05 pm
CytoDyn Announces President Takes Medical Leave of Absence - May 24th, 2023 9:05 pm
CytoDyn to Hold Webcast to Provide a Company Update - Apr 5th, 2023 12:30 pm
Ousted CEO Pourhassan sues CytoDyn to cover his attorney's fees - Jan 24th, 2023 8:32 pm
Kazem Kazempour, CEO of Germantown biotech firm Amarex, charged with securities fraud - Dec 23rd, 2022 1:23 pm
CytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEO - Dec 23rd, 2022 1:00 pm
After ex-CEO Pourhassan's indictment, what's left of CytoDyn? - Dec 21st, 2022 9:59 pm
Ousted CytoDyn CEO Pourhassan indicted for alleged securities fraud - Dec 20th, 2022 8:19 pm
CytoDyn to Host R&D Update on Wednesday, December 7, 2022 - Nov 22nd, 2022 1:30 pm
CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues - Oct 28th, 2022 9:15 pm
CytoDyn Announces Appointment of Additional Directors with Industry Experience - Oct 20th, 2022 12:30 pm